Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Early Phase 1
1(50.0%)
2Total
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07227883Early Phase 1Recruiting

Secretome Treatment for Facial Rejuvenation

Role: lead

NCT06477172Recruiting

Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

Role: lead

NCT07107841Not ApplicableRecruiting

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

Role: lead

NCT06336135Completed

Reduction in Symptoms After Laser Therapy With Acorn aHFS

Role: lead

NCT06764719Recruiting

Cryopreserved Hair Follicles for Disease and Cell Replacement

Role: lead

All 5 trials loaded